Cargando…

Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease

Machado–Joseph disease (MJD) is the most common dominantly-inherited ataxia worldwide with no effective treatment to prevent, stop or alleviate its progression. Neuropeptide Y (NPY) is a neuroprotective agent widely expressed in the mammalian brain. Our previous work showed that NPY overexpression m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duarte-Neves, Joana, Cavadas, Cláudia, Pereira de Almeida, Luís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870889/ https://www.ncbi.nlm.nih.gov/pubmed/33558582 http://dx.doi.org/10.1038/s41598-021-82339-5

Ejemplares similares

Trehalose alleviates the phenotype of Machado–Joseph disease mouse models
por: Santana, Magda M., et al.
Publicado: (2020)

Caloric restriction blocks neuropathology and motor deficits in Machado–Joseph disease mouse models through SIRT1 pathway
por: Cunha-Santos, Janete, et al.
Publicado: (2016)

A Variant in Genes of the NPY System as Modifier Factor of Machado-Joseph Disease in the Chinese Population
por: Ding, Dongxue, et al.
Publicado: (2022)

Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease
por: Miranda, Catarina Oliveira, et al.
Publicado: (2022)

Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment
por: Onofre, Isabel, et al.
Publicado: (2016)

Profiling Microglia in a Mouse Model of Machado–Joseph Disease
por: Campos, Ana Bela, et al.
Publicado: (2022)

Familial spontaneous pneumothorax and Machado–Joseph disease
por: Pelayo, Jerald, et al.
Publicado: (2020)

Cerebellar Rotation Abnormalities Observed in Machado-Joseph Disease
por: Nomura, Taichi, et al.
Publicado: (2020)

Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease
por: Ferreira, Ana F., et al.
Publicado: (2023)

State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change
por: Furtado, Gabriel Vasata, et al.
Publicado: (2019)

Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease
por: Esteves, Sofia, et al.
Publicado: (2015)

Mitochondrial Dysfunction and Decreased Cytochrome c in Cell and Animal Models of Machado–Joseph Disease
por: Almeida, Filipa, et al.
Publicado: (2023)

RNA Interference Mitigates Motor and Neuropathological Deficits in a Cerebellar Mouse Model of Machado-Joseph Disease
por: Nóbrega, Clévio, et al.
Publicado: (2014)

Machado-Joseph Disease: from first descriptions to new perspectives
por: Bettencourt, Conceição, et al.
Publicado: (2011)

T2-hyperintensity in the internal globus pallidus in Machado-Joseph disease
por: Meira, Alex T., et al.
Publicado: (2023)

Silencing Mutant Ataxin-3 Rescues Motor Deficits and Neuropathology in Machado-Joseph Disease Transgenic Mice
por: Nóbrega, Clévio, et al.
Publicado: (2013)

Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010)

Clinical manifestations and gene mutation in a case of Machado-Joseph disease★
por: Zhang, Bin, et al.
Publicado: (2012)

Sentinel Node Biopsy and Lumpectomy in a Patient with Machado–Joseph Disease
por: Aldawoodi, N. N., et al.
Publicado: (2019)

The Homogeneous Azorean Machado-Joseph Disease Cohort: Characterization and Contributions to Advances in Research
por: Lima, Manuela, et al.
Publicado: (2023)

Remote Measurement of Functional Status in Pre-symptomatic and Symptomatic Individuals with Machado-Joseph Disease
por: Miglorini, Elaine Cristina, et al.
Publicado: (2022)

Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado–Joseph Disease
por: Campos, Ana Bela, et al.
Publicado: (2022)

Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets
por: Zeng, Chenming, et al.
Publicado: (2020)

Targeted Deletion of Neuropeptide Y (NPY) Modulates Experimental Colitis
por: Chandrasekharan, Bindu, et al.
Publicado: (2008)

Normal ATXN3 Allele but Not CHIP Polymorphisms Modulates Age at Onset in Machado–Joseph Disease
por: França, Marcondes C., et al.
Publicado: (2012)

Ataxin-3 and Its E3 Partners: Implications for Machado–Joseph Disease
por: Durcan, Thomas M., et al.
Publicado: (2013)

Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3)
por: Raposo, Mafalda, et al.
Publicado: (2014)

Dystonia in Patients with Spinocerebellar Ataxia 3 - Machado-Joseph disease: An Underestimated Diagnosis?
por: Catai, Ligia Maria Perrucci, et al.
Publicado: (2018)

Is the High Frequency of Machado-Joseph Disease in China Due to New Mutational Origins?
por: Li, Tianjiao, et al.
Publicado: (2019)

What is the best way to keep walking and moving around for individuals with Machado-Joseph disease? A scoping review through the lens of Aboriginal families with Machado-Joseph disease in the Top End of Australia
por: Carr, Jennifer J, et al.
Publicado: (2019)

The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples
por: Duarte Lobo, Diana, et al.
Publicado: (2020)

Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease
por: Alves, Sandro, et al.
Publicado: (2008)

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
por: de Assis, Adriano M., et al.
Publicado: (2017)

Machado-Joseph disease in a Sudanese family links East Africa to Portuguese families and allows reestimation of ancestral age of the Machado lineage
por: Martins, Sandra, et al.
Publicado: (2023)

Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph disease
por: Pereira Sena, Priscila, et al.
Publicado: (2023)

High frequency of Machado-Joseph disease identified in Southeastern Chinese kindreds with spinocerebellar ataxia
por: Gan, Shi-Rui, et al.
Publicado: (2010)

Gabapentin for complex regional pain syndrome in Machado-Joseph disease: a case report
por: Lo, Yang-Ching, et al.
Publicado: (2011)

Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease
por: Hernandez-Castillo, Carlos R., et al.
Publicado: (2017)

Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
por: Martier, Raygene, et al.
Publicado: (2019)

Recurrent divergence-insufficiency esotropia in Machado-Joseph disease (spinocerebellar ataxia type 3)
por: Stallworth, Jeannette Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jru4l13r99igo1pk8v0l8uddq3